We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-8.89%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.51B
AUM Growth
-$307M
Cap. Flow
+$14.9M
Cap. Flow %
0.6%
Top 10 Hldgs %
23.56%
Holding
327
New
15
Increased
111
Reduced
164
Closed
21

Top Buys

Rank Stock Value
1
APPS icon
Digital Turbine
APPS
+$22.2M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$11.6M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$7.01M
4
CHUY
Chuy's Holdings, Inc. Common Stock
CHUY
+$6.39M
5
MATV icon
Mativ Holdings
MATV
+$5.91M

Top Sells

Rank Stock Value
1
MIME
Mimecast Limited
MIME
+$15.9M
2
ZGNX
Zogenix, Inc.
ZGNX
+$12.6M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$11.1M
4
NPTN
NEOPHOTONICS CORP
NPTN
+$6.5M
5
COLL icon
Collegium Pharmaceutical
COLL
+$5.04M

Sector Composition

Rank Sector Weight
1 Technology 29.36%
2 Healthcare 23.72%
3 Industrials 14.58%
4 Consumer Discretionary 12.89%
5 Communication Services 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EFSC icon
301
Enterprise Financial Services Corp
EFSC
$2.38B
$205K 0.01%
4,325
– –
HELE icon
302
Helen of Troy
HELE
$680M
$202K 0.01%
1,032
-46
-4% -$9.69K
IWC icon
303
iShares Micro-Cap ETF
IWC
$1.49B
$202K 0.01%
1,567
-10,738
-87% -$1.38M
RRX icon
304
Regal Rexnord
RRX
$11.5B
$202K 0.01%
1,358
-15
-1% -$2.4K
FIBK icon
305
First Interstate BancSystem
FIBK
$3.56B
$200K 0.01%
+5,440
New +$214K
APLE icon
306
Apple Hospitality REIT
APLE
$3.71B
$183K 0.01%
10,175
– –
ABCB icon
307
Ameris Bancorp
ABCB
$5.88B
– –
-12,800
Closed -$636K
AXGN icon
308
Axogen
AXGN
$2.59B
– –
-160,255
Closed -$1.5M
CAG icon
309
Conagra Brands
CAG
$7.07B
– –
-14,718
Closed -$503K
CDNA icon
310
CareDx
CDNA
$2.44B
– –
-29,923
Closed -$1.36M
CYRX icon
311
CryoPort
CYRX
$751M
– –
-46,749
Closed -$2.77M
ECVT icon
312
Ecovyst
ECVT
$1.1B
– –
-53,842
Closed -$551K
EPAM icon
313
EPAM Systems
EPAM
$5.02B
– –
-7,046
Closed -$4.71M
JAZZ icon
314
Jazz Pharmaceuticals
JAZZ
$16.7B
– –
-2,095
Closed -$267K
NEO icon
315
NeoGenomics
NEO
$2.14B
– –
-83,103
Closed -$2.83M
OSK icon
316
Oshkosh
OSK
$9.59B
– –
-1,915
Closed -$216K
PFE icon
317
Pfizer
PFE
$154B
– –
-3,749
Closed -$221K
TER icon
318
Teradyne
TER
$57.1B
– –
-1,300
Closed -$213K
TLS icon
319
Telos
TLS
$302M
– –
-15,563
Closed -$240K
VMD icon
320
Viemed Healthcare
VMD
$355M
– –
-376,602
Closed -$1.97M
AAN
321
DELISTED
The Aaron's Company Inc
AAN
– –
-9,644
Closed -$238K
NUVA
322
DELISTED
NuVasive, Inc.
NUVA
– –
-55,296
Closed -$2.9M
NPTN
323
DELISTED
NEOPHOTONICS CORP
NPTN
– –
-423,249
Closed -$6.5M
IIN
324
DELISTED
IntriCon Corporation
IIN
– –
-149,177
Closed -$2.41M
ARNA
325
DELISTED
Arena Pharmaceuticals Inc
ARNA
– –
-119,426
Closed -$11.1M
10 11 12
13
14

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Rice Hall James & Associates held 327 positions worth $2.51B, down 11% from $2.82B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates's Q1 2022 filing shows 15 new, 111 increased, 164 reduced and 21 closed positions. Its largest new stake was Digital Turbine: 491,443 shares worth $21.5M. The largest sale was Mimecast Limited, an estimated $15.9M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Rice Hall James & Associates's largest Q1 2022 buy was Digital Turbine: 491,443 shares worth $21.5M.
  • Rice Hall James & Associates added most to Neurocrine Biosciences in Q1 2022, an estimated $11.6M increase.
  • Rice Hall James & Associates's biggest Q1 2022 reduction was Mimecast Limited, cutting an estimated $15.9M.
  • Rice Hall James & Associates fully exited Zogenix, Inc. in Q1 2022, selling an estimated $12.6M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $2.51B portfolio in Q1 2022.
  • Rice Hall James & Associates opened 15 new positions and closed 21 in Q1 2022.
  • Rice Hall James & Associates's portfolio value fell 11% quarter-over-quarter to $2.51B.

Based on Rice Hall James & Associates's 13F filing for Q1 2022, filed 5 May 2022.